Joint Call to Action on Pandemic Preparedness and Response: 7 Recommendations for Readiness
The Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation have issued 7 recommendations ...
Tag: Strategic National Stockpile
51 FDA Approved Medical Countermeasures Backed by BARDA
Many health security threats involve bacteria or chemicals for which clinical trials cannot be performed in humans. To overcome this ...
USAMRIID Study Leads to Approval of New Smallpox Vaccine
A new vaccine approved in the U.S. on Sept. 24 prevents both smallpox and the related disease monkeypox in adults. ...
Why Do We Need a New Smallpox Vaccine?
The FDA approved the Jynneos Smallpox and Monkeypox Vaccine last week. The live, non-replicating vaccine is made from a vaccinia ...
FDA Approves Jynneos to Prevent Smallpox and Monkeypox
The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...
20 Years of the Strategic National Stockpile: Response History Timeline
The the nation’s largest reserve of medicines and supplies for use in a public health emergency – the Strategic National ...
Silverlon Wound Dressings Cleared by FDA for Injuries Caused by Mustard Gas
The U.S. Food and Drug Administration (FDA) clearance Silverlon, a product to manage certain blister injuries caused by sulfur mustard, ...
In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures
A crisis has arisen from the simultaneous decrease in the number of pharmaceutical companies developing antibiotics and the dramatic increase ...
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing
Bavarian Nordic A/S announced on Jan. 18 that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised another ...
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox
SIGA Technologies, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United ...
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to Emergent ...
FBI Seeks Tamiflu Supplier for Pandemic Flu Preparedness Program
The Federal Bureau of Investigation (FBI) is seeking suppliers for anti-viral therapeutic Tamiflu to support is Pandemic Flu Preparedness Program ...
Health and Human Services Biodefense Budget Oversight
The House Appropriations Subcommittee on Labor, Health and Human Services, and Education held an oversight hearing focused on the FY2019 ...
Project BioShield: HHS Purchases Anthrax Countermeasure from Elusys Therapeutics
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) will ...
U.S. Seeks to Develop Late-Stage Smallpox Antivirals
The etiological agent responsible for smallpox disease, Variola viridae (VARV) is responsible for the deaths of hundreds of millions of ...
Bavarian Nordic Highlights Smallpox Orders, Vaccine Development
Bavarian Nordic A/S this week updated investors on its progress for the first three quarters of 2017, highlighting MVA-BN IMVAMUNE® ...
First Shipment of ANTHIM Anthrax Treatment Delivered to Strategic National Stockpile
Elusys Therapeutics, Inc. announced today that the company has delivered the first doses of ANTHIM® (obiltoxaximab) Injection, its treatment for ...
Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi
The only FDA-licensed smallpox vaccine, ACAM2000 (Smallpox (Vaccinia) Vaccine, Live), will be acquired from Sanofi by Emergent BioSolutions under a ...
CDC Stockpile Trainer Helps Other Countries Improve Supply Chain Preparedness
Tom Jackson touring proposed medical material storage site in Yaounde, Cameroon in March 2015. One of ...
Elusys Delivers Anthrax Countermeasure Order, Gains Funding for Lyophilization Effort
Elusys Therapeutics, Inc. has received payment from the U.S. federal government for completing the second delivery of its medical countermeasure ...
ADVERTISEMENT.
